Gritstone bio (NASDAQ:GRTS) Downgraded by Zacks Investment Research to Hold

Gritstone bio} stock has undergone multiple analysts rating changes in the recent past.  Gritstone bio Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Gritstone bio (NASDAQ:GRTS) Downgraded by Zacks Investment Research to Hold